Abstract: An RFID tag may execute instructions from an authenticated RFID reader. A tag determines a handle and a first parameter, both of which may be random numbers, and sends the handle to a reader. Upon receiving a challenge from the reader, the tag determines and sends a cryptographic response to the challenge based on an algorithm, a tag key, the first parameter, and the challenge. Upon receiving a message with a second parameter and a tag instruction, the tag executes the tag instruction upon verifying that the second parameter derives from the first parameter and the tag handle.

Abstract: Solid lipid particles comprising a lipid hydrophobic matrix and from about 5 wt. % to about 30 wt. % of curcumin, and methods of making and treatment thereof.

Abstract: A cryptographically-enabled RFID tag stores a primary secret key and derives secondary keys from the primary key. A secondary key may be derived by combining the primary key with one or more other parameters using one or more algorithms. The tag uses a derived secondary key to encrypt or electronically sign a tag response sent to a verifying entity. The verifying entity does not know the derived secondary key, but knows the tag primary key and the parameters and algorithms used to derive the secondary key and can derive all of the potential secondary keys. The verifying entity can then attempt to authenticate the tag or tag response by trying potential secondary keys.

Abstract: Disclosed are various embodiments of lipid multiparticulate compositions comprising at least one active agent, a low flow point excipient, and a high flow point excipient.

Abstract: A valerian composition includes a therapeutically effective pharmaceutical dosage form having a solid core including a polymer in which valerian and a valerian stability improving amount of an acidifying agent are contained. The valerian stability improving amount of acidifying agent being sufficient to impart a pH of 2 to 5 to the polymer.

Abstract: A composition includes a therapeutically effective oral pharmaceutical dosage form that becomes buoyant upon contact with gastric fluid. The dosage form includes an active ingredient combination including an amino acid source and a zinc source, an anionic polymer, an effervescent agent, and a pH buffer. The dosage form is effective for releasing the active ingredient combination while buoyant on gastric fluid.

Abstract: Embodiments are directed to sequential encoding for RFID tags. An encoding line transports an RFID tag from the reading zone of a first reader to the reading zone of a second reader. The first reader communicates with the tag, writes a portion of an identifier to the tag, and sends a tag write status to the second reader. The second reader, situated after the first reader, communicates with the tag, receives the tag write status from the first reader, then determines a remaining portion of the identifier to be written to the tag based on the tag write status. The second reader then attempts to write the remaining portion to the tag. If the attempt fails, the second reader initiates an error-handling procedure.

Abstract: An RFID tag may execute instructions from an authenticated RFID reader. A tag determines a handle and a first parameter, both of which may be random numbers, and sends the handle to a reader. Upon receiving a challenge from the reader, the tag determines and sends a cryptographic response to the challenge based on an algorithm, a tag key, the first parameter, and the challenge. Upon receiving a message with a second parameter and a tag instruction, the tag executes the tag instruction upon verifying that the second parameter derives from the first parameter and the tag handle.

Abstract: A composition includes a therapeutically effective pharmaceutical dosage form including a plurality of individual particulates. The individual particulates respectively have: a core including an active ingredient combination of an L-carnitine and a nootropic substance and a release controlling polymer over the core that substantially prevents release of the active ingredients in stomach acid and permits release of the active ingredients in an intestinal pH environment. The composition may be used to treat conditions associated with a reduction of the amount of L-carnitine in the body and/or cognitive impairment.

Abstract: Embodiments are directed to sequential encoding for RFID tags. An encoding line transports an RFID tag from the reading zone of a first reader to the reading zone of a second reader. The first reader communicates with the tag, writes a portion of an identifier to the tag, and sends a tag write status to the second reader. The second reader, situated after the first reader, communicates with the tag, receives the tag write status from the first reader, then determines a remaining portion of the identifier to be written to the tag based on the tag write status. The second reader then attempts to write the remaining portion to the tag. If the attempt fails, the second reader initiates an error-handling procedure.

Abstract: Data stored in nonvolatile memory on a Radio Frequency Identification (RFID) tag integrated circuit may have a “margin” associated with how strongly the data is written to the memory. Upon receiving a wireless margin read command, the RFID IC determines whether the margin for one of more data values stored in memory exceeds a margin threshold. The IC may determine the margin by applying bias voltages or currents to the memory cells storing the data values. If the determined margin does not exceed the margin threshold, the IC may respond with an error code.

Abstract: Controlled-release therapeutic compositions including melatonin combined with sedative and/or analgesic ingredients are described. The compositions have a solid core including melatonin in an acidified polymeric matrix. A sedative ingredient such as GABA receptor agonist may also be in the acidified polymeric matrix. The composition may include an expedited release portion providing a burst release of active ingredients and a sustained release portion providing a sustained release of active ingredients.

Abstract: A cryptographically-enabled RFID tag stores a primary secret key and derives secondary keys from the primary key. A secondary key may be derived by combining the primary key with one or more other parameters using one or more algorithms. The tag uses a derived secondary key to encrypt or electronically sign a tag response sent to a verifying entity. The verifying entity does not know the derived secondary key, but knows the tag primary key and the parameters and algorithms used to derive the secondary key and can derive all of the potential secondary keys. The verifying entity can then attempt to authenticate the tag or tag response by trying potential secondary keys.

Abstract: Controlled-release therapeutic compositions including melatonin combined with sedative and/or analgesic ingredients are described. The compositions have a solid core including melatonin in an acidified polymeric matrix. A sedative ingredient such as GABA receptor agonist may also be in the acidified polymeric matrix. The composition may include an expedited release portion providing a burst release of active ingredients and a sustained release portion providing a sustained release of active ingredients.

Abstract: Controlled-release therapeutic compositions including melatonin combined with sedative and/or analgesic ingredients are described. The compositions have a solid core including melatonin in an acidified polymeric matrix. A sedative ingredient such as GABA receptor agonist may also be in the acidified polymeric matrix. The composition may include an expedited release portion providing a burst release of active ingredients and a sustained release portion providing a sustained release of active ingredients.

Abstract: Synthesized-beam RFID readers may be used to manage and provide information about RFID tag populations. In one embodiment, two or more synthesized-beam readers synthesize respective RF beams towards a tag location. The synthesized-beam readers may coordinate their pointing by means of a controller, a peer-to-peer network, or by using a master-slave arrangement. The synthesized-beam readers may coordinate their transmissions to increase the RF energy available to a tag at the pointing location.

Abstract: Synthesized-beam RFID readers may be used to manage and provide information about RFID tag populations. In one embodiment, two or more synthesized-beam readers synthesize respective RF beams towards a tag location. The synthesized-beam readers may coordinate their pointing by means of a controller, a peer-to-peer network, or by using a master-slave arrangement. The synthesized-beam readers may coordinate their transmissions to increase the RF energy available to a tag at the pointing location.

Abstract: The present disclosure relates to a new, stable, oil based liquid suspension filled hard capsule dosage form for bismuth salts such as bismuth subsalicylate, a process for its manufacture, methods to deliver bismuth salts to humans or animals via stable hard capsules, and improved methods of treating gastrointestinal disorders with such dosage forms.

Abstract: Solid lipid particles comprising a lipid hydrophobic matrix and from about 5 wt. % to about 30 wt. % of curcumin, and methods of making and treatment thereof.

Abstract: An RFID loss-prevention system (LPS) based on synthesized-beam readers (SBRs) permits authorized items to leave a facility and may perform a security action if an unauthorized item leaves the facility. A checkout reader first authorizes an item tagged with an RFID tag to exit a facility by reading an identifier from the tag, obtaining an exit authorization, and sending the identifier to a database. An SBR configured to direct at least two beams along a facility exit path reads tagged items exiting the facility, determines at least one of a travel direction and a tag location, and uses the determination to indicate that a tag is exiting or has exited the facility. The LPS then uses the database to determine if the exiting/exited tag is authorized to leave the facility.